Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Emerald BioVentures is a life sciences incubator based in North America, focusing on creating companies that enhance human health. The firm invests across various stages, from pre-seed to Series C, and has a portfolio of eight companies. Their mission is to tackle significant challenges in the life sciences sector through advancements in science and medicine.
This firm invests in biotech and healthcare companies addressing complex medical issues such as neurodegenerative diseases, breast cancer, heart failure, and obesity. Check sizes vary, but they typically engage with early to growth-stage companies. Emerald BioVentures is dedicated to developing innovative solutions that meet critical healthcare challenges.
Emerald BioVentures has backed several notable companies, including Aikium, which focuses on inflammasome-related therapies, and Avalo Therapeutics, developing treatments for various conditions. Other investments include BIOS, Bond Biosciences, eGlint, Bask Health, Health Outlook, and Valorum Biologics, which specializes in biosimilars for ophthalmology and oncology.
To pitch Emerald BioVentures, email your deck to information@emerald.bio.
Emerald BioVentures runs a program focused on incubating life sciences startups, providing resources and support to help them grow and succeed in the healthcare market.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.